| Donor-derived CMV-specific T cells reduce the requirement for CMV-directed pharmacotherapy after allogeneic stem cell transplantation E Blyth, L Clancy, R Simms, CKK Ma, J Burgess, S Deo, K Byth, ... Blood, The Journal of the American Society of Hematology 121 (18), 3745-3758, 2013 | 263 | 2013 |
| Managing haematology and oncology patients during the COVID-19 pandemic: interim consensus guidance R Weinkove, Z McQuilten, J Adler, M Agar, E Blyth, A Cheng, R Conyers, ... Med. J. Aust 212 (10), 1, 2020 | 166 | 2020 |
| Prophylactic infusion of cytomegalovirus-specific cytotoxic T lymphocytes stimulated with Ad5f35pp65 gene-modified dendritic cells after allogeneic hemopoietic stem cell … KP Micklethwaite, L Clancy, U Sandher, AM Hansen, E Blyth, ... Blood, The Journal of the American Society of Hematology 112 (10), 3974-3981, 2008 | 134 | 2008 |
| Human cytomegalovirus latency and reactivation in allogeneic hematopoietic stem cell transplant recipients L Stern, B Withers, S Avdic, D Gottlieb, A Abendroth, E Blyth, ... Frontiers in Microbiology 10, 1186, 2019 | 128 | 2019 |
| Long-term control of recurrent or refractory viral infections after allogeneic HSCT with third-party virus-specific T cells B Withers, E Blyth, LE Clancy, A Yong, C Fraser, J Burgess, R Simms, ... Blood advances 1 (24), 2193-2205, 2017 | 128 | 2017 |
| Low-cost generation of Good Manufacturing Practice–grade CD19-specific chimeric antigen receptor–expressing T cells using piggyBac gene transfer and patient-derived materials S Ramanayake, I Bilmon, D Bishop, MC Dubosq, E Blyth, L Clancy, ... Cytotherapy 17 (9), 1251-1267, 2015 | 108 | 2015 |
| Investigation of product-derived lymphoma following infusion of piggyBac-modified CD19 chimeric antigen receptor T cells KP Micklethwaite, K Gowrishankar, BS Gloss, Z Li, JA Street, L Moezzi, ... Blood, The Journal of the American Society of Hematology 138 (16), 1391-1405, 2021 | 107 | 2021 |
| Development of CAR T-cell lymphoma in 2 of 10 patients effectively treated with piggyBac-modified CD19 CAR T cells DC Bishop, LE Clancy, R Simms, J Burgess, G Mathew, L Moezzi, ... Blood, The Journal of the American Society of Hematology 138 (16), 1504-1509, 2021 | 104 | 2021 |
| Adoptive T cell immunotherapy for treatment of ganciclovir‐resistant cytomegalovirus disease in a renal transplant recipient N Macesic, D Langsford, K Nicholls, P Hughes, DJ Gottlieb, L Clancy, ... American Journal of Transplantation 15 (3), 827-832, 2015 | 74 | 2015 |
| EBV-associated primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity MK Gandhi, T Hoang, SC Law, S Brosda, K O’Rourke, JWD Tobin, F Vari, ... Blood, The Journal of the American Society of Hematology 137 (11), 1468-1477, 2021 | 73 | 2021 |
| Single-agent high-dose cyclophosphamide for graft-versus-host disease prophylaxis in human leukocyte antigen–matched reduced-intensity peripheral blood stem cell … KF Bradstock, I Bilmon, J Kwan, K Micklethwaite, E Blyth, S Deren, ... Biology of Blood and Marrow Transplantation 21 (5), 941-944, 2015 | 73 | 2015 |
| BK virus-specific T cells for use in cellular therapy show specificity to multiple antigens and polyfunctional cytokine responses E Blyth, L Clancy, R Simms, S Gaundar, P O'Connell, K Micklethwaite, ... Transplantation 92 (10), 1077-1084, 2011 | 70 | 2011 |
| Establishment and operation of a third-party virus-specific T cell bank within an allogeneic stem cell transplant program B Withers, L Clancy, J Burgess, R Simms, R Brown, K Micklethwaite, ... Biology of Blood and Marrow Transplantation 24 (12), 2433-2442, 2018 | 65 | 2018 |
| Addition of varicella zoster virus–specific T cells to cytomegalovirus, Epstein-Barr virus and adenovirus tri-specific T cells as adoptive immunotherapy in patients undergoing … CKK Ma, E Blyth, L Clancy, R Simms, J Burgess, R Brown, S Deo, ... Cytotherapy 17 (10), 1406-1420, 2015 | 65 | 2015 |
| Identification of SARS-CoV-2 nucleocapsid and spike T-cell epitopes for assessing T-cell immunity E Lee, K Sandgren, G Duette, VV Stylianou, R Khanna, JS Eden, E Blyth, ... Journal of Virology 95 (6), 10.1128/jvi. 02002-20, 2021 | 61 | 2021 |
| Mass Cytometry for the Assessment of Immune Reconstitution After Hematopoietic Stem Cell Transplantation L Stern, HM McGuire, S Avdic, S Rizzetto, B Fazekas de St Groth, ... Frontiers in Immunology 9 (1672), 2018 | 61 | 2018 |
| CMV-specific immune reconstitution following allogeneic stem cell transplantation E Blyth, B Withers, L Clancy, D Gottlieb Virulence 7 (8), 967-980, 2016 | 61 | 2016 |
| Ultra-sensitive droplet digital PCR for the assessment of microchimerism in cellular therapies D Kliman, G Castellano-Gonzalez, B Withers, J Street, E Tegg, ... Biology of Blood and Marrow Transplantation 24 (5), 1069-1078, 2018 | 47 | 2018 |
| Single cell analysis reveals human cytomegalovirus drives latently infected cells towards an anergic-like monocyte state M Shnayder, A Nachshon, B Rozman, B Bernshtein, M Lavi, N Fein, ... Elife 9, e52168, 2020 | 43 | 2020 |
| Influence of stem cell source on outcomes of allogeneic reduced-intensity conditioning therapy transplants using haploidentical related donors K Bradstock, I Bilmon, J Kwan, E Blyth, K Micklethwaite, G Huang, ... Biology of Blood and Marrow Transplantation 21 (9), 1641-1645, 2015 | 39 | 2015 |
Helen Marie McGuireThe University of SydneyEmail verificata su sydney.edu.au
